Growth hormone-releasing hormone agonists ameliorate chronic kidney disease-induced heart failure with preserved ejection fraction.

导出 OA

翻译打印收藏纠错

作者： Angela C,Rieger ^[1] ; Luiza L,Bagno ^[1] ; Alessandro,Salerno ^[1] ; Victoria,Florea ^[1] ; Jose,Rodriguez ^[1] ; Marcos,Rosado ^[1] ; Darren,Turner ^[1] ; Raul A,Dulce ^[1] ; Lauro M,Takeuchi ^[1] ; Rosemeire M,Kanashiro-Takeuchi ^[1] ; Peter,Buchwald ^[2] ; Amarylis C B A,Wanschel ^[2] ; Wayne,Balkan ^[3] ; Ivonne H,Schulman ^[1] ; Andrew V,Schally ^[1] ; Joshua M,Hare ^[4]

作者单位： Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136. ^[1] Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136. ^[2] Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL 33136. ^[3] Department of Medicine, University of Miami Miller School of Medicine, Miami, FL 33136. ^[4] Katz Family Division of Nephrology and Hypertension, University of Miami Miller School of Medicine, Miami, FL 33136. ^[5] Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL 33136; andrew.schally@va.gov jhare@med.miami.edu. ^[6] Endocrine, Polypeptide and Cancer Institute, Veteran Affairs Medical Center, Miami, FL 33125. ^[7] Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136; andrew.schally@va.gov jhare@med.miami.edu. ^[8]

关键词 cardiorenal syndrome chronic kidney disease heart failure with preserved ejection fraction large animal model